Phenomics: Difference between revisions
linkspam |
|||
Line 95: | Line 95: | ||
* [http://www.neurophenomics.info The Laboratory of Neurophenomics] |
* [http://www.neurophenomics.info The Laboratory of Neurophenomics] |
||
* [http://www.phenomics.ucla.edu/ UCLA Consortium for Neuropsychiatric Phenomics] |
* [http://www.phenomics.ucla.edu/ UCLA Consortium for Neuropsychiatric Phenomics] |
||
* [http://www.human-phenotype-ontology.org/ The Human Phenotype Ontology] |
|||
==References== |
==References== |
Revision as of 13:48, 19 January 2011
Phenomics is the study of phenomes — the physical and biochemical traits of organisms — as they change in response to genetic mutation and environmental influences. It is used in functional genomics, pharmaceutical research and metabolic engineering.
RNA interference may be used to generate large numbers of random mutations in organisms such as nematode worms. The resulting phenotypes of the creatures are then analysed. The large volumes of data generated by such work may be stored in a specialised database such as PhenomicDB.[1]
Metabolic flows may be directly studied using technologies such as gas chromatography, nuclear magnetic resonance and mass spectrometry with matrix-assisted laser desorption/ionization (MALDI).[2]
Phenomics centers
- Australian Phenomics Facility
- The Consortium for Neuropsychiatric Phenomics at UCLA was established under the aegis of the NIH Roadmap Initiative in 2007 to advance understanding of neuropsychiatric phenotypes on a genome-wide scale.
- Australian Plant Phenomics Facility
Selected publications
Highly cited publications concerning phenomics[3] include:
- Schilling, C.H.; Edwards, J.S.; Palsson, B.O. (1999), "Toward metabolic phenomics: analysis of genomic data using flux balances", Biotechnology Progress, 15 (3): 288–295, doi:10.1021/bp9900357.
- Gerlai, R. (2002), "Phenomics: fiction or the future?", Trends in Neurosciences, 25 (10): 506–509, doi:10.1016/S0166-2236(02)02250-6.
- Freimer, N.; Sabatti, C. (2003), "The human phenome project", Nature Genetics, 34 (1), Nature Publishing Group: 15–21, doi:10.1038/ng0503-15.
- Warringer, J.; Ericson, E.; Fernandez, L.; Nerman, O.; Blomberg, A. (2003), "High-resolution yeast phenomics resolves different physiological features in the saline response", Proceedings of the National Academy of Sciences of the United States of America, 100 (26): 15724–15729, doi:10.1073/pnas.2435976100.
- Zbuk, K.M.; Eng, C. (2006), "Cancer phenomics: RET and PTEN as illustrative models", Nature Reviews Cancer, 7 (1): 35–45, doi:10.1038/nrc2037.
Further reading
- Houle, D.; Govindaraju, D.R.; Omholt, S. (2010), "Phenomics: the next challenge", Nature Reviews Genetics, 11 (12): 855–66, doi:10.1038/nrg2897
{{citation}}
: Check|first1=
value (help).
External links
- The Aging Research Centre
- The Australian Phenomics Facility
- The Laboratory of Neurophenomics
- UCLA Consortium for Neuropsychiatric Phenomics
- The Plant Phenomics Platform
- The Australian Plant Phenomics Facility
- The Plant Accelerator
- Plant Phenomics platform
- The Australian Plant Phenomics Facility
- The Aging Research Centre
- The Australian Phenomics Facility
- The Laboratory of Neurophenomics
- UCLA Consortium for Neuropsychiatric Phenomics
- The Human Phenotype Ontology
References
- ^ Paul M. Selzer, Richard J. Marhöfer, Andreas Rohwer, "Systems Biology: The Functional Analysis of Genomes", Applied bioinformatics
{{citation}}
: CS1 maint: multiple names: authors list (link) - ^ Uwe Sauer (February 2004), "High-throughput phenomics: experimental methods for mapping fluxomes", Current Opinion in Biotechnology, 15 (1): 58–63, doi:10.1016/j.copbio.2003.11.001, ISSN 0958-1669
- ^ According to a Google scholar search performed 2010-05-01.